Event Brief
Jun 22, 2026 at 8:02 AM ET
AbbVie to buy Apogee for $10.9bn to acquire drug
By The BriefBrief
AbbVie agreed to buy Apogee for $10.9 billion to acquire an inflammatory disease drug.
WHO: AbbVie
WHAT: Agreed to acquire Apogee for $10.9 billion to obtain an inflammatory disease drug
WHEN: Jun 22, 2026 at 7:48 AM ET
WHERE: Location not specified
WHY: To obtain an inflammatory disease drug.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Port Richey names interim city manager after Don King Jr
Port Richey
Jun 22, 2026 at 8:00 AM ET
War robots and UGVs draw attention at Eurosatory 2026
Europe
Jun 22, 2026 at 8:00 AM ET
Rajasthan ATS arrests woman over alleged Jaish links
Rajasthan Ats
Jun 22, 2026 at 7:06 AM ET
Canada signs $1.75B long-range radar deal with Australia
Canada
Jun 22, 2026 at 7:06 AM ET
Page 14926 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
